Boon, P, Engelborghs, S, Hauman, H, Jansen, A, Lagae, L, Legros, B, et al. Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update. Acta Neurol Belg
2012; 112: 119–31.
Ketter, TA, Miller, S, Dell’Osso, B, Calabrese, JR, Frye, MA, Citrome, L. Balancing benefits and harms of treatments for acute bipolar depression. J Affect Disord
2014; 169 (suppl 1): S24–33.
Buelow, JM, Smith, MC. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav
2004; 5: 401–6.
Chapman, SC, Horne, R, Chater, A, Hukins, D, Smithson, WH. Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav
2014; 31: 312–20.
Sajatovic, M, Valenstein, M, Blow, F, Ganoczy, D, Ignacio, R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv
2007; 58: 855–63.
Ettinger, AB, Manjunath, R, Candrilli, SD, Davis, KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav
2009; 14: 324–9.
Olesen, J, Gustavsson, A, Svensson, M, Wittchen, HU, Jönsson, B, CDBE2010 Study Group
et al. The economic cost of brain disorders in Europe. Eur J Neurol
2012; 19: 155–62.
Whiteford, HA, Ferrari, AJ, Degenhardt, L, Feigin, V, Vos, T. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PLoS One
2015; 10: e0116820.
Kessler, RC, Akiskal, HS, Ames, M, Birnbaum, H, Greenberg, P, Hirschfeld, RM, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry
2006; 163: 1561–8.
Getnet, A, Woldeyohannes, SM, Bekana, L, Mekonen, T, Fekadu, W, Menberu, M, et al. Antiepileptic drug nonadherence and its predictors among people with epilepsy. Behav Neurol
2016; 2016: 3189108.
Nakhutina, L, Gonzalez, JS, Margolis, SA, Spada, A, Grant, A. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav
2011; 22: 584–6.
Baldessarini, RJ, Perry, R, Pike, J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol
2008; 23: 95–105.
Leclerc, E, Mansur, RB, Brietzke, E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord
2013; 149: 247–52.
Mitchell, AJ, Selmes, T. Why don't patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat
2007; 13: 336–46.
Sleath, B, Rubin, RH, Huston, SA. Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Compr Psychiatry
2003; 44: 198–204.
Serretti, A, Chiesa, A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol
2009; 29: 259–66.
Kaufman, KR, Wong, S, Sivaraaman, K, Anim, C, Delatte, D. Epilepsy and AED-induced decreased libido – the unasked psychosocial comorbidity. Epilepsy Behav
2015; 52(Pt A): 236–8.
Henning, OJ, Nakken, KO, Træen, B, Mowinckel, P, Lossius, M. Sexual problems in people with refractory epilepsy. Epilepsy Behav
2016; 61: 174–9.
Sivaraaman, K, Mintzer, S. Hormonal consequences of epilepsy and its treatment in men. Curr Opin Endocrinol Diabetes Obes
2011; 18: 204–9.
Michael, A, O’Keane, V. Sexual dysfunction in depression. Hum Psychopharmacol
2000; 15: 337–45.
Grover, S, Ghosh, A, Sarkar, S, Chakrabarti, S, Avasthi, A. Sexual dysfunction in clinically stable patients with bipolar disorder receiving lithium. J Clin Psychopharmacol
2014; 34: 475–82.
La Torre, A, Giupponi, G, Duffy, DM, Pompili, M, Grözinger, M, Kapfhammer, HP, et al. Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs. Pharmacopsychiatry
2014; 47: 1–6.
Kaufman, KR, Struck, PJ. Gabapentin-induced sexual dysfunction. Epilepsy Behav
2011; 21: 324–6.
Kandeel, FR, Koussa, VK, Swerdloff, RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev
2001; 22: 342–88.
Capogrosso, P, Ventimiglia, E, Boeri, L, Capitanio, U, Gandaglia, G, Dehò, F, et al. Sexual functioning mirrors overall men's health status, even irrespective of cardiovascular risk factors. Andrology
2017; 5: 63–9.
Viigimaa, M, Doumas, M, Vlachopoulos, C, Anyfanti, P, Wolf, J, Narkiewicz, K, et al. Hypertension and sexual dysfunction: time to act. J Hypertens
2011; 29: 403–7.
Francis, ME, Kusek, JW, Nyberg, LM, Eggers, PW. The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol
2007; 178: 591–6.
McCabe, MP, Sharlip, ID, Lewis, R, Atalla, E, Balon, R, Fisher, AD, et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med
2016; 13: 153–67.
Lehrner, A, Flory, JD, Bierer, LM, Makotkine, I, Marmar, CR, Yehuda, R. Sexual dysfunction and neuroendocrine correlates of posttraumatic stress disorder in combat veterans: preliminary findings. Psychoneuroendocrinology
2016; 63: 271–5.
Kumsar, NA, Kumsar, Ş, Dilbaz, N. Sexual dysfunction in men diagnosed as substance use disorder. Andrologia
2016; 48: 1229–35.
Naranjo, CA, Shear, NH, Lanctôt, KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol
1992; 32: 897–904.
Kennedy, SH, Dugré, H, Defoy, I. A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder. Int Clin Psychopharmacol
2011; 26: 151–8.
Seidman, S. Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions. Int J Impot Res
2006; 18 (suppl 1): S33–8.
Rajkumar, RP, Kumaran, AK. Depression and anxiety in men with sexual dysfunction: a retrospective study. Compr Psychiatry
2015; 60: 114–8.
Blumentals, WA, Gomez-Caminero, A, Brown, RR, Vannappagari, V, Russo, LJ. A case-control study of erectile dysfunction among men diagnosed with panic disorder. Int J Impot Res
2004; 16: 299–302.
Badour, CL, Gros, DF, Szafranski, DD, Acierno, R. Problems in sexual functioning among male OEF/OIF veterans seeking treatment for posttraumatic stress. Compr Psychiatry
2015; 58: 74–81.
Smaldone, M, Sukkarieh, T, Reda, A, Khan, A. Epilepsy and erectile dysfunction: a review. Seizure
2004; 13: 453–9.
Hellmis, E. Sexual problems in males with epilepsy – an interdisciplinary challenge!
2008; 17: 136–40.
Aull-Watschinger, S, Pataraia, E, Baumgartner, C. Sexual auras: predominance of epileptic activity within the mesial temporal lobe. Epilepsy Behav
2008; 12: 124–7.
Suffren, S, Braun, CM, Guimond, A, Devinsky, O. Opposed hemispheric specializations for human hypersexuality and orgasm?
2011; 21: 12–9.
Fiszman, A, Alves-Leon, SV, Nunes, RG, D’Andrea, I, Figueira, I. Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy Behav
2004; 5: 818–25.
Baslet, G, Roiko, A, Prensky, E. Heterogeneity in psychogenic nonepileptic seizures: understanding the role of psychiatric and neurological factors. Epilepsy Behav
2010; 17: 236–41.
Doumas, M, Douma, S. Sexual dysfunction in essential hypertension: myth or reality?
J Clin Hypertens (Greenwich)
2006; 8: 269–74.
Iovino, P, Pascariello, A, Limongelli, P, Tremolaterra, F, Consalvo, D, Sabbatini, F, et al. The prevalence of sexual behavior disorders in patients with treated and untreated gastroesophageal reflux disease. Surg Endosc
2007; 21: 1104–10.
Missori, P, Scollato, A, Formisano, R, Currà, A, Mina, C, Marianetti, M, et al. Restoration of sexual activity in patients with chronic hydrocephalus after shunt placement. Acta Neurochir (Wien)
2009; 151: 1241–4.
La Torre, A, Giupponi, G, Duffy, D, Conca, A. Sexual dysfunction related to psychotropic drugs: a critical review – part I: antidepressants. Pharmacopsychiatry
2013; 46: 191–9.
Montejo, AL, Llorca, G, Izquierdo, JA, Rico-Villademoros, F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry
2001; 62 (suppl 3): 10–21.
Fossey, MD, Hamner, MB. Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety
1994–1995; 1: 233–6.
Uhde, TW, Tancer, ME, Shea, CA. Sexual dysfunction related to alprazolam treatment of social phobia. Am J Psychiatry
1988; 145: 531–2.
Kaufman, KR. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav
2011; 21: 1–11.
Calabrò, RS, Italiano, D, Militi, D, Bramanti, P. Levetiracetam-associated loss of libido and anhedonia. Epilepsy Behav
2012; 24: 283–4.
Herzog, AG, Drislane, FW, Schomer, DL, Pennell, PB, Bromfield, EB, Dworetzky, BA, et al. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology
2005; 65: 1016–20.
Gil-Nagel, A, López-Muñoz, F, Serratosa, JM, Moncada, I, García-García, P, Alamo, C. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure
2006; 15: 142–9.
Svalheim, S, Taubøll, E, Luef, G, Lossius, A, Rauchenzauner, M, Sandvand, F, et al. Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults. Epilepsy Behav
2009; 16: 281–7.
Husain, AM, Carwile, ST, Miller, PP, Radtke, RA. Improved sexual function in three men taking lamotrigine for epilepsy. South Med J. 2000; 93: 335–6.
Grimm, RH Jr, Grandits, GA, Prineas, RJ, McDonald, RH, Lewis, CE, Flack, JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension
1997; 29(Pt 1): 8–14.
La Torre, A, Giupponi, G, Duffy, D, Conca, A, Catanzariti, D. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry
2015; 48: 1–6.
Brixius, K, Middeke, M, Lichtenthal, A, Jahn, E, Schwinger, RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol
2007; 34: 327–31.
Fogari, R, Zoppi, A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep
2002; 4: 202–10.
Coulson, M, Gibson, GG, Plant, N, Hammond, T, Graham, M. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis. Toxicol Appl Pharmacol
2003; 192: 154–63.
Lindquist, M, Edwards, IR. Endocrine adverse effects of omeprazole. BMJ
1992; 305: 451–2.
Cascorbi, I. Drug interactions – principles, examples and clinical consequences. Dtsch Arztebl Int
2012; 109: 546–56.